G298-0425 Screening compound: N-[2-(3,4-dimethoxyphenyl)ethyl]-3-[7-(4-methoxyphenyl)-8-oxo-7H,8H-[1,2,4]triazolo[4,3-a]pyrazin-3-yl]propanamide

G298-0425 Screening compound: N-[2-(3,4-dimethoxyphenyl)ethyl]-3-[7-(4-methoxyphenyl)-8-oxo-7H,8H-[1,2,4]triazolo[4,3-a]pyrazin-3-yl]propanamide
G298-0425 Screening compound: N-[2-(3,4-dimethoxyphenyl)ethyl]-3-[7-(4-methoxyphenyl)-8-oxo-7H,8H-[1,2,4]triazolo[4,3-a]pyrazin-3-yl]propanamide alternative view

Chemical Structure Depiction of ChemDiv screening compound G298-0425
N-[2-(3,4-dimethoxyphenyl)ethyl]-3-[7-(4-methoxyphenyl)-8-oxo-7H,8H-[1,2,4]triazolo[4,3-a]pyrazin-3-yl]propanamide

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

G298-0425

Molecular Formula

C25H27N5O5 (C25 H27 N5 O5)

Compound Name

N-[2-(3,4-dimethoxyphenyl)ethyl]-3-[7-(4-methoxyphenyl)-8-oxo-7H,8H-[1,2,4]triazolo[4,3-a]pyrazin-3-yl]propanamide

IUPAC name

N-[2-(34-dimethoxyphenyl)ethyl]-3-[7-(4-methoxyphenyl)-8-oxo-7H8H-[124]triazolo[43-a]pyrazin-3-yl]propanamide

SMILES

COc(cc1)ccc1N(C=Cn1c2nnc1CCC(NCCc(cc1)cc(OC)c1OC)=O)C2=O

InChI

InChI=1S/C25H27N5O5/c1-33-19-7-5-18(6-8-19)29-14-15-30-22(27-28-24(30)25(29)32)10-11-23(31)26-13-12-17-4-9-20(34-2)21(16-17)35-3/h4-9,14-16H,10-13H2,1-3H3,(H,26,31)

InChI Key

KVPJRNAFHLOSBW-UHFFFAOYSA-N

MDL Number (MFCD)

MFCD14995941

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

477.52

Hydrogen Bond Acceptors Count

9.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

11.00

Number of Nitrogen and Oxygen Atoms

10

Partition Coefficient, logP

0.015

Distribution Coefficient, logD

0.015

Water Solubility, LogSw

-1.95

Polar Surface Area

86.214

Acid Dissociation Constant (pKa)

14.38

Base Dissociation Constant (pKb)

-4.87

Number of Chiral Centers

0.00

Percent sp3 carbon bonding

28.00

G298-0425 in Drug Discovery

Included in Screening Libraries

300k Representative Compounds Library (Bemis-Murcko Clustering Algorithm) (286253 compounds)

Histone Deacetylases (HDAC) Targeted Library (9760 compounds)

Included in 1.7M Stock Database

Therapeutical areas:
  • Cancer
  • Nervous system
  • Hemic and lymphatic
  • Endocrine
  • Immune system
Mechanism of action:
  • Epigenetic

References: we are preparing a list of scientific research reports with G298-0425 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound G298-0425?
Check Price and Availability of G298-0425, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of G298-0425 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for G298-0425
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for G298-0425
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of G298-0425 available by request